Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex
Sexual Health2019Vol. 17(1), pp. 91–95
Citations Over Time
Aaron J. Siegler, Lauren Ahlschlager, Elizabeth M. Rosenthal, Patrick S. Sullivan, Colleen F. Kelley, Eli S. Rosenberg, Travis Sanchez, Reneé H. Moore, C. Christina Mehta, Michael P. Cecil
Abstract
Condoms are highly effective for HIV prevention, yet are not currently indicated by the US Food and Drug Administration (FDA) for anal sex. We surveyed a national sample of men who have sex with men to assess whether FDA label indication could affect anticipated condom use, and to determine levels of perceived condom failure for anal sex. We found that 69% of respondents anticipated that a label indication change would increase their likelihood of condom use. Median perceived failure was 15%. We anticipate that these results may aid the FDA in developing standards for a label indication for anal sex.
Related Papers
- → Vaginal thrush: quality of life and treatments(2010)14 cited
- AIDS patient present with thrush as the first symptom: Two cases report(2002)
- → Differences on the wing-formula of Eyebrowed Thrush, Brown-headed Thrush, Pale Thrush and Izu Thrush(2020)
- → First record of a Grey-sided Thrush (Turdus feae) and a Mistle Thrush (Turdus viscivorus) in Korea(2021)
- Tales from Thrush Green(1995)